Quantitative Systematic Strategies LLC Iovance Biotherapeutics, Inc. Transaction History

Quantitative Systematic Strategies LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 25, 2019	SELL	$9.78 - $24.52 $118,895 - $298,089	-12,157 Closed	0 $0
Q1 2019 Apr 15, 2019	SELL	$8.41 - $11.26 $7,720 - $10,336	-918 Reduced 7.02%	12,157 $116,000
Q4 2018 Feb 12, 2019	BUY	$7.51 - $11.93 $98,193 - $155,984	13,075 New	13,075 $116,000

313

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.28B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.